Anti-vascular endothelial growth factor receptor in colorectal cancer: A review
In recent years, the treatment of metastatic colorectal cancer (mCRC) has dramatically changed thanks to the advent of new drugs called molecular targeted therapies such as anti-vascular endothelial growth factor (anti-VEGF) and anti-epidermal growth factor (anti-EGFR). Bevacizumab, aflibercept and...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Gastrointestinal Intervention
2023-07-01
|
Series: | International Journal of Gastrointestinal Intervention |
Subjects: | |
Online Access: | https://www.ijgii.org/journal/view.html?doi=10.18528/ijgii230011 |